{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:52:48Z","timestamp":1783745568816,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"publisher","award":["Linea D1- 2017, code R4124500587"],"award-info":[{"award-number":["Linea D1- 2017, code R4124500587"]}],"id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00423-018-1659-0","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T18:06:31Z","timestamp":1521050791000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?"],"prefix":"10.1007","volume":"403","author":[{"given":"Emanuela","family":"Traini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Bellantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Elisa","family":"Tempera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"De Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino Pio","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1259-2491","authenticated-orcid":false,"given":"Marco","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"issue":"6","key":"1659_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0039-6060(05)80094-7","volume":"118","author":"JM Monchik","year":"1995","unstructured":"Monchik JM (1995) Normocalcemic hyperparathyroidism. Surgery 118(6):917\u2013923. \n                    https:\/\/doi.org\/10.1016\/S0039-6060(05)80094-7","journal-title":"Surgery"},{"issue":"10","key":"1659_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archsurg.1992.01420100015003","volume":"127","author":"AE Siperstein","year":"1992","unstructured":"Siperstein AE, Shen W, Chan AK, Duh QY, Clark OH (1992) Normocalcemic hyperparathyroidism biochemical and symptom profiles before and after surgery. Arch Surg 127(10):1157\u20131156 discussion 1161-1153","journal-title":"Arch Surg"},{"issue":"3","key":"1659_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","volume":"121","author":"E Lundgren","year":"1997","unstructured":"Lundgren E, Rastad J, Thrufjell E, Akerstrom G, Ljunghall S (1997) Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121(3):287\u2013294. \n                    https:\/\/doi.org\/10.1016\/S0039-6060(97)90357-3","journal-title":"Surgery"},{"issue":"1","key":"1659_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","volume":"16","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Silverberg SJ, Bilezikian JP (2013) Normocalcemic primary hyperparathyroidism. J Clin Densitom 16(1):33\u201339. \n                    https:\/\/doi.org\/10.1016\/j.jocd.2012.12.001","journal-title":"J Clin Densitom"},{"issue":"2","key":"1659_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/cen.12819","volume":"83","author":"G Kontogeorgos","year":"2015","unstructured":"Kontogeorgos G, Trimpou P, Laine CM, Olerod G, Lindahl A, Landin-Wilhelmsen K (2015) Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: a long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden. Clin Endocrinol 83(2):277\u2013284. \n                    https:\/\/doi.org\/10.1111\/cen.12819","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1659_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/cen.12569","volume":"82","author":"C Berger","year":"2015","unstructured":"Berger C, Almohareb O, Langsetmo L, Hanley DA, Kovacs CS, Josse RG, Adachi JD, Prior JC, Towheed T, Davison KS, Kaiser SM, Brown JP, Goltzman D (2015) Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol 82(3):359\u2013368. \n                    https:\/\/doi.org\/10.1111\/cen.12569","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1659_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94(2):335\u2013339. \n                    https:\/\/doi.org\/10.1210\/jc.2008-1763","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1659_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959\u2013968. \n                    https:\/\/doi.org\/10.1001\/jamasurg.2016.2310","journal-title":"JAMA Surg"},{"issue":"10","key":"1659_CR9","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561\u20133569. \n                    https:\/\/doi.org\/10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1659_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28(1):1\u201319. \n                    https:\/\/doi.org\/10.1007\/s00198-016-3716-2","journal-title":"Osteoporos Int"},{"issue":"8","key":"1659_CR11","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/jc.2013-1518","volume":"98","author":"E Koumakis","year":"2013","unstructured":"Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, Borderie D, Kahan A, Cormier C (2013) Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab 98(8):3213\u20133220. \n                    https:\/\/doi.org\/10.1210\/jc.2013-1518","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1659_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","volume":"36","author":"TJ Wade","year":"2012","unstructured":"Wade TJ, Yen TW, Amin AL, Wang TS (2012) Surgical management of normocalcemic primary hyperparathyroidism. World J Surg 36(4):761\u2013766. \n                    https:\/\/doi.org\/10.1007\/s00268-012-1438-y","journal-title":"World J Surg"},{"key":"1659_CR13","doi-asserted-by":"publisher","first-page":"128352","DOI":"10.1155\/2012\/128352","volume":"2012","author":"LM Amaral","year":"2012","unstructured":"Amaral LM, Queiroz DC, Marques TF, Mendes M, Bandeira F (2012) Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone? J Osteoporos 2012:128352\u2013128354. \n                    https:\/\/doi.org\/10.1155\/2012\/128352","journal-title":"J Osteoporos"},{"issue":"11","key":"1659_CR14","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00268-009-9931-7","volume":"33","author":"CP Lombardi","year":"2009","unstructured":"Lombardi CP, Raffaelli M, Traini E, De Crea C, Corsello SM, Bellantone R (2009) Video-assisted minimally invasive parathyroidectomy: benefits and long-term results. World J Surg 33(11):2266\u20132281. \n                    https:\/\/doi.org\/10.1007\/s00268-009-9931-7","journal-title":"World J Surg"},{"issue":"5","key":"1659_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00423-008-0384-5","volume":"393","author":"CP Lombardi","year":"2008","unstructured":"Lombardi CP, Raffaelli M, Traini E, Di Stasio E, Carrozza C, De Crea C, Zuppi C, Bellantone R (2008) Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbeck's Arch Surg 393(5):639\u2013645. \n                    https:\/\/doi.org\/10.1007\/s00423-008-0384-5","journal-title":"Langenbeck's Arch Surg"},{"issue":"7","key":"1659_CR16","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM, Bauer DC, Orwoll ES, Bilezikian JP (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98(7):2734\u20132741. \n                    https:\/\/doi.org\/10.1210\/jc.2013-1300","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1659_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s12020-012-9694-z","volume":"42","author":"A Garcia-Martin","year":"2012","unstructured":"Garcia-Martin A, Reyes-Garcia R, Munoz-Torres M (2012) Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women. Endocrine 42(3):764\u2013766. \n                    https:\/\/doi.org\/10.1007\/s12020-012-9694-z","journal-title":"Endocrine"},{"issue":"5","key":"1659_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","volume":"55","author":"TF Marques","year":"2011","unstructured":"Marques TF, Vasconcelos R, Diniz E, Rego D, Griz L, Bandeira F (2011) Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat? Arq Bras Endocrinol Metabol 55(5):314\u2013317. \n                    https:\/\/doi.org\/10.1590\/S0004-27302011000500003","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"3","key":"1659_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1530\/EC-15-0030","volume":"4","author":"E Vignali","year":"2015","unstructured":"Vignali E, Cetani F, Chiavistelli S, Meola A, Saponaro F, Centoni R, Cianferotti L, Marcocci C (2015) Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy. Endocr Connect 4(3):172\u2013178. \n                    https:\/\/doi.org\/10.1530\/EC-15-0030","journal-title":"Endocr Connect"},{"key":"1659_CR20","unstructured":"Berger C, Langsetmo L, Hanley, D, Hadachi J, Kovacs C, Brown J, Josse R, Goltzman D (2011) Relative prevalence of normocalcemic and hypercalcemic hyperparathyroidism in a community-dwelling cohort. Paper presented at the 33rd Annual Meeting of the American Society of Bone and Mineral Research, San Diego, California"},{"issue":"10","key":"1659_CR21","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani G, Hertig A, Paillard M, Houillier P (2003) Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 88(10):4641\u20134648. \n                    https:\/\/doi.org\/10.1210\/jc.2002-021404","journal-title":"J Clin Endocrinol Metab"},{"key":"1659_CR22","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2014-4432","volume":"100","author":"G Chen","year":"2015","unstructured":"Chen G, Xue Y, Zhang Q, Xue T, Yao J, Huang H, Liang J, Li L, Lin W, Lin L, Shi L, Cai L, Wen J (2015) Is normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab 100:2420\u20132424. \n                    https:\/\/doi.org\/10.1210\/jc.2014-4432","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1659_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MED.0000000000000198","volume":"22","author":"M Pawloska","year":"2015","unstructured":"Pawloska M, Cusano NE (2015) An overview of normocalcemic primary hyperparathyroidism. Diabetes Curr Opin Endocrinol Diabetes Obes 22(6):413\u2013421. \n                    https:\/\/doi.org\/10.1097\/MED.0000000000000198","journal-title":"Diabetes Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"1659_CR24","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131300. \n                    https:\/\/doi.org\/10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1659_CR25","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92(8):3001\u20133005. \n                    https:\/\/doi.org\/10.1210\/jc.2006-2802","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1659_CR26","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","volume":"67","author":"DS Rao","year":"1988","unstructured":"Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67(6):1294\u20131298. \n                    https:\/\/doi.org\/10.1210\/jcem-67-6-1294","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1659_CR27","first-page":"388","volume":"33","author":"C Crea De","year":"2013","unstructured":"De Crea C, Raffaelli M, Traini E, Giustozzi E, Oragano L, Bellantone R, Lombardi CP (2013) Is there a role for video-assisted parathyroidectomy in regions with high prevalence of goitre? Acta Otorhinolaryngol Ital 33(6):388\u2013392","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"1659_CR28","doi-asserted-by":"publisher","unstructured":"de la Plaza LR, Ramia \u00c1ngel JM, Arteaga Peralta V, Garc\u00eda Amador C, L\u00f3pez Marcano AJ, Medina Velasco AA, Gonz\u00e1lez Sierra B, Manuel V\u00e1zquez A, Latorre Fragua RA (2017) Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review. Eur Arch Otorhinolaryngol. \n                    https:\/\/doi.org\/10.1007\/s00405-017-4836-9","DOI":"10.1007\/s00405-017-4836-9"},{"issue":"8","key":"1659_CR29","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/jc.2011-0569","volume":"96","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2011) Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 96(8):2377\u20132385. \n                    https:\/\/doi.org\/10.1210\/jc.2011-0569","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1659_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2214\/AJR.07.3160","volume":"191","author":"JM Suh","year":"2008","unstructured":"Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191(3):908\u2013911. \n                    https:\/\/doi.org\/10.2214\/AJR.07.3160","journal-title":"AJR Am J Roentgenol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-018-1659-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-018-1659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-018-1659-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T20:21:22Z","timestamp":1552508482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-018-1659-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1007\/s00423-018-1659-0","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}